The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
New clinical trials presented at the American Diabetes Association's Scientific Sessions show that survodutide has promising results for reducing HbA1c levels and improving insulin sensitivity, with additional favorable changes in glucose-related biomarkers.
A community-engaged intervention aimed at reducing opioid overdose deaths did not demonstrate a statistically significant impact. The HEALing Communities Study Consortium conducted a trial spanning January 2020 to June 2022, coinciding with the COVID-19 pandemic and an increase in fentanyl-related overdoses.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Nestle introduces Vital Pursuit, a new food brand tailored for people taking weight-loss drugs like Wegovy, focusing on high-protein, nutrient-dense meals while navigating regulatory concerns and competition in the growing market targeting GLP-1 medication users.
Cyberattack on Ascension hospitals across the U.S. compromises patient care, leading to medication errors, delayed lab results, and patient safety risks, as health workers struggle without access to critical electronic systems.
A recent study reveals that surgeons are most frequently reported for unprofessional behavior by coworkers, while pediatric-focused physicians are least likely to be reported.
A recent article reveals a significant imbalance in the U.S. anesthesia workforce due to increased demand and inadequate supply, exacerbated by the COVID-19 pandemic.